Table 2.
Correlation analysis between miR-1254 expression and the clinicopathological characteristics of patients with thyroid cancer
| Characteristics | No. of patients | Mean ± SD | P value |
|---|---|---|---|
| Total no. of patients | 85 | ||
| Age (year) | |||
| < 60 | 41 (48.2%) | 10.01 ± 1.94 | 0.289 |
| ≤ 60 | 44 (51.8%) | 9.59 ± 1.69 | |
| Gender | |||
| Male | 35 (41.2%) | 9.89 ± 1.38 | 0.317 |
| Female | 50 (58.8%) | 9.53 ± 1.77 | |
| Invasion | |||
| T0-T2 | 54 (63.5%) | 9.45 ± 1.26 | 0.005** |
| T3-T4 | 31 (36.5%) | 10.37 ± 1.68 | |
| Lymphatic metastasis | |||
| N0 | 26 (30.6%) | 10.14 ± 1.74 | 0.006** |
| N1-N3 | 59 (69.4%) | 9.25 ± 1.13 | |
| Distal metastasis | |||
| M0 | 18 (21.2%) | 10.87 ± 1.75 | 0.016* |
| M1 | 67 (78.8%) | 9.48 ± 2.21 | |
| TNM stage | |||
| 0 & I | 24 (28.2%) | 10.74 ± 2.07 | 0.012* |
| II & III & IV | 61 (71.8%) | 9.64 ± 1.64 |
*
Indicated statistical significance (P < 0.05);
**
Indicated statistical significance (P < 0.01).